Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

Status Completed

Clinical Trial Summary

The study is designed to measure salivary matrix metalloproteinase-1 (MMP-1) using the enzyme-linked immunosorbent assay (ELISA) we developed previously in patients with oral potentially malignant disorders (OPMD), oral squamous cell carcinoma (OSCC), and healthy participants. The purpose of this study is to evaluate the potential of the newly developed salivary MMP-1 ELISA as an adjunctive tool to aid in diagnosis of OSCC.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Mouth Neoplasms
Oral Squamous Cell Carcinoma
Squamous Cell Carcinoma of Head and Neck

Clinical Trial Details

NCT number	NCT05049408
Study type	Observational
Source	S&T Biomed Co., Ltd.
Contact
Status	Completed
Phase
Start date	February 17, 2011
Completion date	December 7, 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04543266` - Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning
Not yet recruiting	`NCT06438939` - NBI for Early Diagnosis of OPMD/OSCC	N/A
Recruiting	`NCT05024383` - Dissecting the Heterogeneity of Oral Cancer Pain	N/A
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Not yet recruiting	`NCT06174428` - Validity of Viome's Oral/Throat Cancer Test
Recruiting	`NCT05098119` - Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)	Phase 2
Recruiting	`NCT05069857` - Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients	Phase 2
Not yet recruiting	`NCT03619304` - Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line	N/A
Active, not recruiting	`NCT01772706` - Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer	N/A
Recruiting	`NCT05893888` - Safety and Efficacy Study of PRV211 in Subjects With Oral Squamous Cell Carcinoma	Phase 1/Phase 2
Recruiting	`NCT05125055` - Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC	Phase 2/Phase 3
Not yet recruiting	`NCT06055868` - People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Not yet recruiting	`NCT06130007` - A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.	Phase 2
Recruiting	`NCT05798793` - Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma	Phase 3
Recruiting	`NCT02739204` - Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma	Phase 2
Completed	`NCT05708209` - The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124
Recruiting	`NCT05862168` - Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial	Phase 2
Recruiting	`NCT05451303` - Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Recruiting	`NCT05902455` - Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
Not yet recruiting	`NCT05803915` - Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy	Phase 2